FDA's FIRST GENERICS POLICY DRAWS PRAISE

DECEMBER 01, 2006

The FDA's new First Generics Policy has evoked a positive response from leaders of the generic drug industry, who are predicting that the action will speed the marketing of lower-cost prescription medicines. "Ensuring that at least one generic medicine will be available to consumers when a brand's patent expires is good news for consumers," officials at the Generic Pharmaceutical Association (GPhA) said.

Because of the FDA's action, "consumers will have more timely access to safe, effective, and affordable generic medicines," GPhA said. "By making generics more accessible, [the] FDA is saving consumers and our entire health care system millions of dollars."




SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.